# Verteporfin

## Visudyne inj 15mg/vial

| 藥物代碼           | IVIS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Subfoveal choroidal neovascularization: Treatment of predominantly classic subfoveal choroidal neovascularization due to age-related macular degeneration, pathologic myopia, or presumed ocular histoplasmosis.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 副作用             | >10%: Local: Injection site reactions (including injection site discoloration, edema, extravasation, hemorrhage, inflammation, pain, and rash)Ocular: Blurred vision, flashes of light, visual acuity decreased, visual field defects (including scotoma)1% to 10%: Cardiovascular: Atrial fibrillation, hypertension, peripheral vascular disorder, varicose veinsCentral nervous system: Fever, hypoesthesia, sleep disturbance, vertigo Dermatologic: Eczema, photosensitivity Gastrointestinal: Constipation, gastrointestinal cancers, nausea Genitourinary: Prostatic disorder Hematologic: Anemia, leukocytosis, leukopenia Hepatic: Liver function tests increasedNeuromuscular & skeletal: Arthralgia, arthrosis, back pain (primarily during infusion), myasthenia, weakness Ocular: Diplopia, lacrimation disorder Treatment site: Blepharitis, cataracts, conjunctivitis/conjunctival injection, dry eyes, ocular itching, severe vision loss with or without subretinal/retinal or vitreous hemorrhage (decrease in 4 lines or more within 7 days of treatment [1% to 5%]) Otic: Hearing loss Renal: Albuminuria, creatinine increased Respiratory: Cough, pharyngitis, pneumonia Miscellaneous: Flu-like syndrome |
| 禁忌               | Known hypersensitivity to verteporfin or any component of the formulation; porphyria                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 藥物保存方式       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 用法用量           | Dosing: Adult 6 mg/m2 (depending on patient's total BSA) via IV infusion. Followed by light therapy 15 minutes after start of 10-minute verteporfin infusion. May repeat at 3-month intervals (if evidence of choroidal neovascular leakage)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 肝功能異常         | 無需調整劑量  患有中度或嚴重肝功能損傷或膽道阻塞的病人應小心使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 附帶說明           | (UptoDate)Verteporfin and its metabolite are excreted in breast milk. Milk concentrations were up to 66% of plasma levels in 1 woman following infusion; the metabolite was still detected 48 hours later. Due to the potential for serious adverse reactions in the nursing infant, the manufacturer recommends that nursing be discontinued or treatment be postponed, taking into account the importance of treatment to the mother.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 注射劑給藥建議途徑 | IVD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 輸注點滴液         | 【D5W】 可選                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| IVD 用法建議       | 建議以10分鐘緩慢滴注. 建議使用孔徑不小於1.2μm過濾器的輸注管線.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 注意事項           | 1.不可用生理食鹽水，會沉澱。 2.以7mL"無菌注射用水"加入小瓶中，此時濃度為2mg/mL的7.5mL溶液，溶液呈不透明暗綠色溶液。 3.本品溶解稀釋後須立即使用，限單次使用。(25℃下，4個小時內化學物理安定) 4.抽出所需劑量，再以D5W稀釋成30mL輸注液，輸注10分鐘。 5.建議使用臨床試驗使用的含孔徑不小於1.2μm過濾器的輸注管線。 6.注射時應預防滲漏。若發生滲漏，應立即停止輸注，保護該部位避免強光直射直到腫脹及皮膚變色的情形消失，冷敷可減輕症狀。 7.若藥品配製時潑灑出，須以濕布擦拭。避免與眼睛及皮膚接觸。                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

